Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP797245.RAnyl08orMN0eISJxx3K8exLEljCufASu0fCo0zVSuHbk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP797245.RAnyl08orMN0eISJxx3K8exLEljCufASu0fCo0zVSuHbk130_assertion type Assertion NP797245.RAnyl08orMN0eISJxx3K8exLEljCufASu0fCo0zVSuHbk130_head.
- NP797245.RAnyl08orMN0eISJxx3K8exLEljCufASu0fCo0zVSuHbk130_assertion wasGeneratedBy ECO_0000203 NP797245.RAnyl08orMN0eISJxx3K8exLEljCufASu0fCo0zVSuHbk130_provenance.
- NP797245.RAnyl08orMN0eISJxx3K8exLEljCufASu0fCo0zVSuHbk130_assertion wasDerivedFrom befree-2016 NP797245.RAnyl08orMN0eISJxx3K8exLEljCufASu0fCo0zVSuHbk130_provenance.
- NP797245.RAnyl08orMN0eISJxx3K8exLEljCufASu0fCo0zVSuHbk130_assertion SIO_000772 20197461 NP797245.RAnyl08orMN0eISJxx3K8exLEljCufASu0fCo0zVSuHbk130_provenance.
- NP797245.RAnyl08orMN0eISJxx3K8exLEljCufASu0fCo0zVSuHbk130_assertion evidence source_evidence_literature NP797245.RAnyl08orMN0eISJxx3K8exLEljCufASu0fCo0zVSuHbk130_provenance.
- NP797245.RAnyl08orMN0eISJxx3K8exLEljCufASu0fCo0zVSuHbk130_assertion description "[CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP797245.RAnyl08orMN0eISJxx3K8exLEljCufASu0fCo0zVSuHbk130_provenance.